Niraparib
ATC L01XK02 · 11 markets · 36 records
US 5 records · 5 shown of 5
GB 5 records · 4 shown of 4
HK 4 records · 0 shown of 0
4 records · 0 manufacturers 4 registros · 0 fabricantes 4 个记录 · 0 个厂家 4 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
CA 3 records · 3 shown of 3
Only this ingredient
- 100 mgtabletZEJULA
ES 3 records · 3 shown of 3
Only this ingredient
- 100 mgtabletZEJULA
TW 3 records · 1 shown of 1
Only this ingredient
- 100 mgtabletZEJULA截永樂錠100毫克
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
AU 2 records · 1 shown of 1
Only this ingredient
- 100 mgtabletZEJULA
SG 2 records · 2 shown of 2
EU 2 records · 0 shown of 0
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
FR 2 records · 1 shown of 1
Only this ingredient
- 100 mgtabletZEJULA 100 mg, comprimé pelliculé
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
MX 1 records · 0 shown of 0
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
| Strength / form / release | US | GB | CA | AU | SG | ES | MX | TW | HK | EU | FR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 100 mg tablet | ZEJULA | ZEJULA | ZEJULA | ZEJULA | ZEJULA | ZEJULA | ZEJULA 截永樂錠100毫克 | ZEJULA 100 mg, comprimé pelliculé | |||
| 200 mg tablet | ZEJULA | ZEJULA | |||||||||
| 300 mg tablet | ZEJULA | ||||||||||
| 100 mg capsule | ZEJULA | ||||||||||
| 100 mg Combination Abiraterone 500 mg + Niraparib 100 mg tablet | AKEEGA | AKEEGA | AKEEGA | AKEEGA | |||||||
| 50 mg Combination Abiraterone 500 mg + Niraparib 50 mg tablet | AKEEGA | AKEEGA | AKEEGA | AKEEGA | |||||||
unknown | ZEJULA | ZEJULA | |||||||||
| Combination Abiraterone + Niraparib tablet | AKEEGA | AKEEGA 澤截膜衣錠100/500毫克 澤截膜衣錠50/500毫克 | |||||||||
| Combination Abiraterone Acetate + Niraparib unknown | AKEEGA | AKEEGA | |||||||||
| Combination Abiraterone Acetate 500 mg + Niraparib tablet | AKEEGA 100 mg/500 mg, comprimé pelliculé |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
3 more strength/form rows are recorded only in HK · EU · FR and are not shown in this table. Hay 3 filas de concentración/forma registradas solo en HK · EU · FR que no se muestran en esta tabla. 另有 3 个规格/剂型仅在 HK · EU · FR 有记录(未在本表显示)。 另有 3 個規格/劑型僅在 HK · EU · FR 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.